"HLA-DR2 Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A broad specificity HLA-DR antigen that is associated with HLA-DRB1 CHAINS encoded by DRB1*01:15 and DRB1*01:16 alleles.
Descriptor ID |
D015802
|
MeSH Number(s) |
D12.776.395.550.509.400.440.400.020 D12.776.543.550.440.400.440.400.020 D23.050.301.500.400.400.440.400.020 D23.050.301.500.450.400.440.389.750 D23.050.705.552.410.400.440.389.020 D23.050.705.552.450.400.440.389.750
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "HLA-DR2 Antigen".
Below are MeSH descriptors whose meaning is more specific than "HLA-DR2 Antigen".
This graph shows the total number of publications written about "HLA-DR2 Antigen" by people in this website by year, and whether "HLA-DR2 Antigen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HLA-DR2 Antigen" by people in Profiles.
-
Nalawade SA, Ji N, Raphael I, Pratt A, Kraig E, Forsthuber TG. Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4. Cell Immunol. 2018 09; 331:38-48.
-
Ji N, Somanaboeina A, Dixit A, Kawamura K, Hayward NJ, Self C, Olson GL, Forsthuber TG. Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis. J Immunol. 2013 Nov 15; 191(10):5074-84.
-
Fuentes-Mattei E, Rivera E, Gioda A, Sanchez-Rivera D, Roman-Velazquez FR, Jimenez-Velez BD. Use of human bronchial epithelial cells (BEAS-2B) to study immunological markers resulting from exposure to PM(2.5) organic extract from Puerto Rico. Toxicol Appl Pharmacol. 2010 Mar 15; 243(3):381-9.
-
Kort JJ, Kawamura K, Fugger L, Weissert R, Forsthuber TG. Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice. J Neuroimmunol. 2006 Apr; 173(1-2):23-34.